AFAP1 and endometrial carcinoma: AFAP-AS1 could affect the proliferation, migration, and invasion of ESCs, and contributed to ESC angiogenesis as well as tumor metastasis, which accelerates the angiogenesis and invasion of endometrial carcinoma [9].